v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities    
Net loss $ (1,521,707) $ (1,840,521)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 532,384 122,060
Stock-based compensation 632,610 125,086
Change in fair value of marketable securities (37,964)
Inventory reserve (27,000)
Operating lease costs 126,007 160,827
Changes in operating assets and liabilities:    
Accounts receivable (475,677) (966,969)
Inventories (1,255,105) 442,684
Prepaid expenses and other (121,704) (333,893)
Long-term deposits (796,411) (280,000)
Accounts payable and accrued expenses (468,230) 762,999
Operating lease obligations (119,092) (109,631)
Customer deposits 391,064 (91,589)
Net cash used in operating activities (3,140,825) (2,008,947)
Cash Flows from Investing Activities    
Purchases of property and equipment (361,045)
Net investment in marketable securities (6,580,128)
Net cash used in investing activities (6,580,128) (361,045)
Cash Flows from Financing Activities    
Net proceeds from rights offering 1,524,001
Net proceeds from registered direct offering 8,323,748
Repayments of finance lease obligations (4,310) (3,791)
Net cash provided by (used in) financing activities 9,843,439 (3,791)
Net change in cash and cash equivalents 122,486 (2,373,783)
Cash, Cash Equivalents, and Restricted Cash – Beginning of the Period 11,685,395 19,315,984
Cash and Cash Equivalents – End of the Period 11,807,881 16,942,201
Supplemental disclosures    
Cash paid for interest 5,456 8,156
Cash paid for income taxes 814 9,903
Non-Cash Investing and Financing Activities    
Common Stock issued upon vesting of RSUs 154 2
Reclassification of subscription liability to stockholders’ equity upon closing of rights offering 6,704,304
Reclassification of deferred offering costs to additional paid-in-capital upon closing of rights offering $ 164,807